Loading...
GRAIL, Inc.
GRAL•NASDAQ
Healthcare
Medical - Diagnostics & Research
$40.29
$0.57(1.44%)
GRAIL, Inc. (GRAL) Financial Performance & Income Statement Overview
Review GRAIL, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
34.90%
↑ 34.90%
Operating Income Growth
-44.46%
↓ 44.46%
Net Income Growth
-38.30%
↓ 38.30%
Operating Cash Flow Growth
3.13%
↑ 3.13%
Operating Margin
-1618.34%
↓ 1618.34%
Gross Margin
-31.67%
↓ 31.67%
Net Profit Margin
-1464.53%
↓ 1464.53%
ROE
-75.07%
↓ 75.07%
ROIC
-76.29%
↓ 76.29%
GRAIL, Inc. (GRAL) Income Statement & Financial Overview
Review GRAIL, Inc.'s (GRAL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $38.25M | $28.65M | $31.97M | $26.72M |
| Cost of Revenue | $54.22M | $50.88M | $49.88M | $48.63M |
| Gross Profit | -$15.97M | -$22.23M | -$17.91M | -$21.91M |
| Gross Profit Ratio | -$0.42 | -$0.78 | -$0.56 | -$0.82 |
| R&D Expenses | $48.33M | $78.23M | $94.20M | $101.63M |
| SG&A Expenses | $72.64M | $83.04M | $108.25M | $103.89M |
| Operating Expenses | $121.66M | $161.27M | $1.62B | $205.51M |
| Total Costs & Expenses | $175.19M | $212.16M | $1.67B | $254.14M |
| Interest Income | $9.37M | $11.66M | $2.81M | $2.90M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $39.44M | $39.23M | $39.39M | $40.00M |
| EBITDA | -$97.50M | -$144.28M | -$180.97M | -$187.43M |
| EBITDA Ratio | -$2.55 | -$5.04 | -$5.66 | -$7.01 |
| Operating Income | -$136.94M | -$183.51M | -$1.64B | -$227.42M |
| Operating Income Ratio | -$3.58 | -$6.40 | -$51.34 | -$8.51 |
| Other Income/Expenses (Net) | $9.94M | $11.10M | $2.81M | $2.94M |
| Income Before Tax | -$126.99M | -$172.41M | -$1.64B | -$224.48M |
| Income Before Tax Ratio | -$3.32 | -$6.02 | -$51.25 | -$8.40 |
| Income Tax Expense | -$29.93M | -$46.72M | -$53.14M | -$5.57M |
| Net Income | -$97.07M | -$125.69M | -$1.59B | -$218.91M |
| Net Income Ratio | -$2.54 | -$4.39 | -$49.59 | -$8.19 |
| EPS | -$2.89 | -$3.94 | -$51.06 | -$7.05 |
| Diluted EPS | -$2.89 | -$3.94 | -$51.06 | -$7.05 |
| Weighted Avg Shares Outstanding | $33.89M | $31.88M | $31.05M | $31.05M |
| Weighted Avg Shares Outstanding (Diluted) | $33.89M | $31.88M | $31.05M | $31.05M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan